The FDA has HALTED the use of the Johnson & Johnson vaccine over BLOOD CLOT concerns!
The new announcement from the FDA and CDC means all federal health channels — mass vaccination sites, community health centers and the like — that were previously administering the Johnson & Johnson vaccine will immediately stop for the time being, according to a federal health official.
The agencies are recommending that states do the same, but it will be up to the individual states to make that decision because they are given a separate allocation of doses.
The pause happened because this type of blood clot is not listed on the list of potential adverse side effects that were part of the emergency use authorization for J&J. While officials are stressing it is rare, they want health care providers to have time to understand what potential side effects are and how to best treat them.
The CDC and FDA came to a decision late last night, a federal health official said. The two agencies will do a press call at 10 a.m. this morning to answer more questions about the development. [CNN]
- US CDC and FDA recommend US pause Johnson & Johnson vaccine use over blood clot concerns “out of an abundance of caution.” The six reported cases were among more than 6.8 million doses of the vaccine administered in the US.
- US Covid-19 cases and hospitalizations are increasing – particularly for younger people – while deaths are going down, the CDC director said.